1. |
Franco AMM, Medina FMC, Balbi GGM, et al. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: a cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature[J]. Lupus, 2020, 29(12): 1528-1543. DOI: 10.1177/0961203320949667.
|
2. |
Bick RL. Antiphospholipid thrombosis syndromes[J]. Hematol Oncol Clin North Am, 2003, 17(1): 115-147. DOI: 10.1016/s0889-8588(02)00103-x.
|
3. |
晏颂欣, 张蜀澜, 李永哲. 抗磷脂抗体谱诊断抗磷脂抗体综合征的研究进展[J]. 中华风湿病学杂志, 2019, 23(9): 626-631. DOI: 10.3760/cma.j.issn.1007-7480.2019.09.010.Yan SX, Zhang SL, Li YZ. Research progress of antiphospholipid antibody profile in the diagnosis of antiphospholipid antibody syndrome[J]. Chin J Rheumatol, 2019, 23(9): 626-631. DOI: 10.3760/cma.j.issn.1007-7480.2019.09.010.
|
4. |
Cavazzana I, Andreoli L, Limper M, et al. Update on antiphospholipid syndrome: ten topics in 2017[J]. Curr Rheumatol Rep, 2018, 20(3): 15. DOI: 10.1007/s11926-018-0718-4.
|
5. |
Uludag G, Onghanseng N, Tran ANT, et al. Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations[J]. J Ophthalmic Inflamm Infect, 2021, 11(1): 1-11. DOI: 10.1186/s12348-021-00240-8.
|
6. |
Yang HK, Moon KW, Ji MJ, et al. Primary antiphospholipid syndrome presenting with homonymous quadrantanopsia[J]. Am J Ophthalmol Case Rep, 2018, 10: 208-210. DOI: 10.1016/j.ajoc.2018.03.001.
|